Waltham, Mass. — May 6, 2026 — Leads & Copy — Crescent Biopharma, Inc. (Nasdaq: CBIO) will present at investor conferences in May.
Management is scheduled to present at the BofA Securities 2026 Healthcare Conference, Stifel Virtual Targeted Oncology Forum, and TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA.
A live webcast of each presentation will be available in the Investors section of Crescent’s website at https://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days.
Crescent Biopharma’s vision is to build a world leading oncology company bringing therapies for cancer patients. The Company’s clinical-stage pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors.
The BofA Securities 2026 Healthcare Conference fireside chat is scheduled for Wednesday, May 13, 2026, at 4:20 p.m. PT (7:20 p.m. ET) in Las Vegas. The 2026 Stifel Virtual Targeted Oncology Forum virtual fireside chat will take place on Wednesday, May 20, 2026, at 2:30 p.m. ET. The TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA virtual fireside chat is scheduled for Tuesday, May 26, 2026, at 11:30 a.m. ET.
Source: Crescent Biopharma
